StonvexLoading…
StonvexStonvexStonvexCore line items from AGYS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Annual 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $236.37M | $155.98M | $76.67M | $275.62M |
Operating Income | $30.40M | $18.67M | $4.52M | $22.59M |
Net Income | $26.50M | $16.60M | $4.89M | $23.23M |
EPS (Diluted) | $0.93 | $0.59 | $0.17 | $0.82 |
Total Assets | $475.18M | $425.57M | $426.05M | $434.37M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $81.45M | $59.34M | $55.56M | $73.04M |
Free Cash Flow OCF − CapEx | $32.74M | $10.02M | $-4.98M | $52.34M |
Shares Outstanding | 28.10M | 28.04M | 28.04M | 28.02M |